Many transplant patients can be successfully treated in an outpatient environment without compromising quality of care and safety. This approach may reduce hospitalization days, cost of treatment and improve the quality of life and satisfaction of the treated patients. Such process demands an education program to the patient and families and a dedicated skilled outpatient service ready to attend and support the patient 24 hours a day with safety and confidence. From January 1997 to October 1998 11 patients (female 10) median age of 50 (35-63) were treated at the outpatient bone marrow transplant service. Seven pts had breast cancer (second consolidation -6), 3 with ovarian cancer and 1 with myeloma. The patients were treated with Melphalan 200mg/M 2 divided in 2 days, and stem cells were reinfused the following day. G-CSF 5ugr/Kg and oral quinolones were given from day +2. Daily assessment and supportive care was given until hospitalization or engraftment by the nursing team with physician support. 10 out of 11 patients required hospitalization for a median of 4 days. Mucositis developed in 7 patients. 9 patients engrafted on day +10 and 2 on day +11 with a median of 5 days of neutropenia. There was no treatment-related mortality. All pts who underwent this treatment as second consolidation were grateful for the possibility of being treated in the outpatient environment. Ambulatory transplant can be performed only in a dedicated set-up that includes skilled caregivers, 24 hours nursing and physician availability that radiate confidence to the patients. This approach increases the continuity care, the responsibility and sense of autonomy of advanced practice nurses and develop their counseling skills as well as their ability to participate more actively in the entire transplant program.
S243
S244
